TRBC2-Specific Antibody-Drug Conjugate Shows Robust Efficacy in T-Cell Lymphomas and Leukemias

Engineered, Detectable Oncolytic Virus Reprograms Immunity and Extends Survival in Brain Cancer

Artificial Intelligence Detects Pancreatic Cancer More Accurately Than Radiologists

Less Toxic, More Effective: Real-World Evidence Supports Reduced Immunotherapy Dose in Melanoma

Nanotherapy Reprograms Glioblastoma Immunity Through Nose-to-Brain Delivery

ESMO’s Road Map for Safe and Effective Use of AI-LLMs in Cancer Care: 23 Rules from 20 Experts

AI Analysis of Thymic Health Predicts Immunotherapy Success, Cutting Death Risk by 44%

Disarming Prostate Cancer: Dual Enzyme Blockade Weakens Tumors and Boosts Drug Response

Molecular Trojan Horse: Peptide Nanotubes Offer a Path to Defeat Drug-Resistant Tumors

LED-Activated SnOx Nanoflake Therapy Destroy Tumor Cells with Precision

Dr. Eleni Lagkadinou Discusses How AbbVie Is Advancing Targeted Innovation for HT Cancers

The VAPOR 2 Trial and the Potential of Water Vapor Ablation in Prostate Cancer Treatment

The V Foundation and CVC Collaborate to Advance Breast Cancer Vaccine Research

NEJM Study Confirms Low-Dose Aspirin Halves Recurrence in Colorectal Cancer

Sugary Drinks Drive Colorectal Cancer Metastasis via SORD Pathway, Study Finds

The Role of Third-Generation TKIs in Overcoming Chronic Myeloid Leukemia Resistance

SUNMO Trial: A New Chapter for Transplant-Ineligible Large B-Cell Lymphoma

Overcoming Drug Discovery Challenges Through AI-Driven Innovation

The Integration of START and CURC Could Play a Pivotal Role in Advancing Clinical Trials

The V Foundation for Cancer Research and CVC Partner to Accelerate Breast Cancer Vaccines

Ferroptosis as a New Strategy: Iron-Driven Cell Death Targets Cancer Stem Cells

Redesigned CD40 Antibody Triggers Systemic Tumor Regression and Complete Remission

RNA Isoform RUNX1C Identified as Molecular 'Switch' Behind Chemoresistance in Blood Cancer

Bacteria Cloak Viruses to Safely Deliver Cancer-Killing Payloads into Solid Tumors

Genetic Testing Boosts Safety, Reduces Chemotherapy Side Effects in GI Cancer

New Study Uncovers Hidden Disease in 42% of Ovarian Cancer Patients in Remission

New Radioimmunotherapy Strategy Eradicates Cancer Stem Cells in Ovarian Cancer

Dr. Iris Kuss: ARANOTE Trial Results Signal a New Era in Prostate Cancer Treatment

Global Data Warns of Secondary Cancers Linked to CAR-T Therapy, Urging Monitoring

Supercharging Chemotherapy with a Mitochondrial Strategy for Lung Cancer Treatment

Advancing ADCs and Bispecifics Across Oncology and Immunology

How SkinJect’s Microneedle-Patch Could Improve Skin Cancer Treatment Outcomes

Promising Targeted Immunotherapy Improves Survival in HPV16+ Cancers

Targeting the ‘Don’t Eat Me’ Signal: The Future of Macrophage Checkpoint Inhibitors

Shining a Light on Lung Cancer: The Promise of Abenacianine

How to Improve Access to CAR T-cell Therapy: The Role of Policy and Innovation

Overcoming Challenges and Expanding Access to CAR T-Cell Therapy

A Patient Advocacy Perspective on Expanding Access to CAR T-cell Therapy

AMPLITUDE: Niraparib Combo Improves rPFS in HRR-Altered mCS Prostate Cancer

Enhertu-pertuzumab Combo Shows 44% Risk Reduction in HER2+ Breast Cancer

FDA Approves Darolutamide Plus ADT for mCS Prostate Cancer

ctDNA-Guided Camizestrant Switch Redefines 1st-Line Breast Cancer Treatment

World-First Clinical Trial Confirms Exercise Boosts Survival in Colon Cancer

How the Integration of START and CURC Is Advancing Cancer Research and Clinical Trials

EpCAM-Targeting ADC CX-2051 Shows Promising Efficacy in Advanced Colorectal Cancer

Oncologists Struggle with Innovation Overload: 'The Growing Chasm in Cancer Care'

New AI-Powered Urine Test Detects Prostate Cancer with Higher Precision than PSA

How SkinJect's Microneedle Technology Could Transform the Treatment of Skin Cancer

A Breakthrough in Personalizing Lung Cancer Therapy with the GO Chip for Tumor Monitoring

The Next Generation of ADCs and Their Potential for Non-Small Cell Lung Cancer